Molecular targeting of CDK9 in oncology therapeutics: avenues for translational impact
{{output}}
Background: Cyclin-dependent kinase 9 (CDK9) is a central regulator of RNA polymerase II elongation and has emerged as a therapeutic target in tumors characterized by transcriptional addiction. Growing interest in selective inhib... ...
